– USA, CA – Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Kristen Miranda to its Board of Directors, effective March 1, 2021.
Also, Ms. Miranda was appointed to the Compensation Committee.
“Increasing patient access to Inogen’s innovative solutions is our mission and vision. We are privileged to have someone with Kristen’s deep healthcare background, as well as extensive payor relations skills, join us at this stage,” said CEO, Nabil Shabshab. “Her expertise will be a significant asset as we work to increase payor acceptance of our products, and we look forward to Kristen’s guidance and leadership as a member of our Board.”
Ms. Miranda fills the vacancy on the Board and the Compensation Committee created by the resignation of Scott Beardsley, who resigned effective February 12, 2021, having served on Inogen’s Board since 2017.
Dr. Heath Lukatch, Board Chairman added, “I want to welcome Kristen to Inogen’s board and I would like to thank Scott Beardsley for his extensive contributions to Inogen over the past three years. He was an integral member of our team as we successfully grew the company, launched our latest innovative portable oxygen concentrator, the Inogen One G5, and expanded our product line through the New Aera acquisition.”
About Kristen Miranda
Kristen Miranda has served as Aetna’s West Region President since 2017, having profit and loss accountability for an organization spanning 14 states. Before joining Aetna, she served as the Chief Integration Officer for Agilon Health from 2016 to 2017 and in various senior leadership roles for Blue Shield of California from 2006 to 2016 including SVP, Strategic Partnerships, and Innovation as well as VP, Provider Network Management. Before that, Ms. Miranda held leadership roles at various healthcare firms including Wellpoint from 2003 to 2006, CIGNA from 1998 to 2003, Health Net from 1995 to 1998, Dignity Health from 1993 to 1995, and First Health from 1989 to 1993.
“I am delighted to be working with Inogen’s talented and inspired executive team and Board of Directors,” said Kristen Miranda. “Their best-in-class portable oxygen concentrators provide enhanced freedom and independence to oxygen therapy patients worldwide, and I look forward to contributing to the next phase of Inogen’s growth as we continue to seek ways to increase patient access to our technologies, expand the business, and enhance shareholder value.”
Ms. Miranda earned a Bachelor of Arts degree in Anthropology from the University of California, Davis, and is a nationally known speaker on innovation in healthcare.
About Inogen
We are a medical technology company offering innovative respiratory products for use in the homecare setting. We primarily develop, manufacture and market innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
For more information: https://www.inogen.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.